Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Coral Gables, FL
SEC filing record 1 source field available
Fiscal year end
31 December
CATALYST PHARMACEUTICALS, INC. has filed 1,380 SEC EDGAR filings since 30 Apr 2003

SEC filing history

Showing 426-450 of 1,000 matching filings.

Per page
25
Current page
18
4

FORM 4 FOR 12-06-2022

Filing date
08 Dec 2022
Reporting date
06 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 12-06-2022

Filing date
08 Dec 2022
Reporting date
06 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 12-06-2022

Filing date
08 Dec 2022
Reporting date
06 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 12-06-2022

Filing date
08 Dec 2022
Reporting date
06 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 12-06-2022

Filing date
08 Dec 2022
Reporting date
06 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 12-06-2022

Filing date
08 Dec 2022
Reporting date
06 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 12-06-2022

Filing date
08 Dec 2022
Reporting date
06 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 12-06-2022

Filing date
08 Dec 2022
Reporting date
06 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-22-2022

Filing date
23 Nov 2022
Reporting date
22 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-21-2022

Filing date
23 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-21-2022

Filing date
23 Nov 2022
Reporting date
21 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-18-2022

Filing date
22 Nov 2022
Reporting date
18 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-15-2022

Filing date
17 Nov 2022
Reporting date
15 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-15-2022

Filing date
17 Nov 2022
Reporting date
15 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-11-2022

Filing date
15 Nov 2022
Reporting date
11 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-11-2022

Filing date
15 Nov 2022
Reporting date
11 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-11-2022

Filing date
15 Nov 2022
Reporting date
11 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 11-11-2022

Filing date
15 Nov 2022
Reporting date
11 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-82644

SC 13G filing

Filing date
14 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82644

SC 13G/A filing

Filing date
07 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 09-23-2022

Filing date
26 Sep 2022
Reporting date
23 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 FOR 09-16-2022

Filing date
20 Sep 2022
Reporting date
16 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .